Hunan Fangsheng Pharmaceutical Co.,Ltd.’s Net Profit Rose 101.1% in First Quarter of 2023

Hunan Fangsheng Pharmaceutical Co.,Ltd. (湖南方盛制药股份有限公司) (603998.SH) reported a net profit of 63 million yuan in the first quarter of 2023, up 101.1% year-on-year.

Meanwhile, the company posted 436.8 million yuan in revenue, up 3.3% year-on-year.

At the end of the reporting period, it had 3 billion yuan in total assets and 1.4 billion yuan in total liabilities, with a liability-to-asset ratio of 46.7%.